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Abstract 
The protective effects of Semen Hoveniae extract (SHE) from Hovenia dulcis Thunb. 
(Rhamnaceae) on the acute alcohol-induced liver injury were investigated in vivo 
using mice as test models. In the present study, SHE (150, 300, 600 mg/kg/d) were 
given to mice by intragastric administration for four days. Mice were gavaged with 
60% ethanol 10 ml/kg after the last dose of the extract. Six hours after alcohol 
administration, liver injury was evaluated by biochemical examination. Lipid 
peroxidation and the activity of antioxidants were measured by spectrophotometric 
method. In mice, administration of SHE significantly decreased the activities of 
alanine amino transferase (ALT) and aspartate transaminase (AST) in serum. 
Administration of SHE also protected against alcohol-induced alcohol dehydrogenase 
(ADH) elevation in mice. Concurrently, there was an augmentation in the activities of 
antioxidant enzymes such as superoxide dismutase (SOD), glutathione-S-transferase 
(GST) and glutathione (GSH), and it also facilitated the alcohol metabolism. Acute 
toxicity test showed that a single dose of oral SHE up to 22 g/kg did not result in any 
death or toxic side effects of mice in 14 days’ observation. These results demonstrate 
that SHE could protect against acute alcohol-induce liver injure without any toxic side 
effects. Therefore, Semen Hoveniae has the potential to develop a clinically useful 
agent which could protect the liver from alcohol-induced injury.  
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Introduction 
Alcoholic liver disease encompasses a broad spectrum of morphological features 
ranging from minimal injury to advanced liver damage (Arteel et al., 2003). Liver 
disease in the alcoholic is due to ethanol hepatotoxicity linked to its metabolism and 
the resulting production of toxic acetaldehyde.  
Ethanol is mainly metabolized in the liver through three major pathways with 
different subcellular locations: alcohol dehydrogenase (ADH) in the cytosol, aldehyde 
dehydrogenase (ALDH) in the mitochondria, and microsomal ethanol oxidizing 
system in the endoplasmic reticulum (Lieber, 1997). All of them lead to over 
production of reactive oxygen species, including superoxide, peroxide, and hydroxyl 
radical, which can cause complete degradation of lipids, proteins, and DNA (Wu & 
Cederbaum, 2003). Additionally, alcohol exposure impairs enzymatic and 
non-enzymatic mechanisms that protect cells against reactive oxygen species, such as 
superoxide dismutase (SOD) and glutathione (GSH) (Wu & Cederbaum, 2003). 
Enhanced reactive oxygen species production and compromised antioxidant activity 
result in oxidative stress, which has been demonstrated to play a pivotal role in 
alcohol-induced liver injury (Cederbaum, 2001; Dey & Cederbaum, 2006).  
Recently, a potential measure for the prevention of liver injury due to alcohol 
could resort to plants that are rich in flavonoids, which are exceptionally efficient 
antioxidants and radical scavengers (Bors et al., 1999). Different classes of flavonoids 
are produced in plants and are regularly ingested within the diet (Haslam, 1998; Aoa 
et al., 2009). It has been shown that the extract of green tea, a substance rich in the 
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procyanidin epigallocatechin gallate, protects the liver against necrosis in the enteral 
model of alcohol-induced injury (Arteel et al., 2002). Semen Hoveniae, the seed of 
the Hovenia dulcis Thunb. (Rhamnaceae), was found to show neuroprotective (Li et 
al., 2005) and hepatoprotective (Hase et al., 1997) effects. But the protective activity 
of Semen Hoveniae against acute alcohol-induced liver injury has not been studied, as 
far as we know.  
The main objective of this study was to assess the effects of 
Semen Hoveniae extract on alcohol-induced liver injury. The levels of the hepatic 
ADH, SOD, GSH and glutathione-S-transferase (GST) were measured, and serum 
aspartate transaminase (AST) and alanine amino transferase (ALT) concentrations 
were also investigated. Additionally, the blood alcohol content, hepatic triglyceride 
(TG) level and the content of alcohol metabolite-malondialdehyde (MDA) were also 
measured. 
Materials and methods 
Preparation of Semen Hoveniae extract 
Semen Hoveniae were purchased from Tong-Ren-Tang Pharmaceutical Group 
(Shanghai) and identiﬁed as the seeds of Hovenia dulcis by Professor Lu-Ping Qin 
(The School of Pharmacy, Second Military Medical University, Shanghai, China). A 
voucher specimen was deposited with the number SY3225 in the Department of 
Pharmacognosy, School of Pharmacy, Second Military Medical University. The seeds 
(1 kg) were pulverized in a motor driven grinder to prepare the extract. After 
refluxing extraction with 8 L 75% (v/v) analytical reagent alcohol twice for 1 h each 
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time, the extract was filtered and then the solvent was evaporated to dryness under 
reduced pressure in a rotary evaporator. The extracturm was freeze-dried 
for in vivo evaluation. The yield of Semen Hoveniae extract (SHE) was 10.78 %. 
Animals and treatments  
Ninety male kunming mice, obtained from Shanghai Si-Lai-Ke Experimental Animal 
Ltd. (Shanghai China), with an initial body weight of 20 ± 2 g, were used in this study. 
They were housed in a regulated environment (22 ± 2°C) with a 12 h dark and 12 h 
light cycle (08:00-20:00, light), and free access to food and tap water. All animal 
treatments were strictly in accordance with international ethical guidelines and the 
National Institutes of Health Guide concerning the Care and Use of Laboratory 
Animals, and the experiments were carried out with the approval of the Committee of 
Experimental Animal Administration of the University.   
Forty animals were randomly divided into four groups of ten each. 
One of the groups served as control and the other three groups were administrated 
with SHE (150, 300, 600 mg/kg d) for four consecution days. Animals in the model 
group received an equal volume of vehicle as control. The animals were fasted for 12 
h before the last administration of the drugs. All animals were treated orally with 60% 
ethanol (10 ml/kg) after the last dose of the drugs. SHE and alcohol were 
administered using intragastric tube. One hour later, animals were sacrificed and 
blood samples were collected and heparinized for the measurement of the alcohol 
level. 
Another fifty animals were also randomly divided into five groups with ten mice 
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in each group. In the test groups, mice were given SHE 150, 300, 600 mg/kg/d by 
gavage for four consecution days, and the control were treated with an equal volume 
of water. The animals were fasted for 12 h before the last administration of the drugs. 
All animals were treated orally with 60% ethanol (10 ml/kg) after the last dose of the 
drugs except mice in normal control group. Six hours later, animals were decapitated 
and blood was collected for the test of serum ALT and AST level. The livers were 
immediately removed and cleaned in 0.9% sodium chloride (4°C), then were cut into 
small pieces and stored at -80°C for biochemical assays. 
Ethanol assay  
Blood alcohol concentrations were determined using blood samples collected one 
hour after the administration of alcohol, with an enzymatic alcohol test kit (Sigma 
Diagnostics). Ethanol concentration was determined by measuring absorbance at 366 
nm resulting from the reduction of NAD+ to NADH by alcohol dehydrogenase 
(Bergmeyer, 1998).  
Serum measurements and hepatic triglyceride assay  
Those blood samples collected 6 h after the administration of alcohol were kept at 
room temperature for 1 h. The serum samples were separated by centrifugation at 
1500 × g for 15 min, and aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) were measured spectrophotometrically using an automated 
analyzer (Bayer-Opera) to assess the hepatic functions. 
Liver tissue was homogenized in 0.9% NaCl (1:19) and hepatic TG contents 
were measured by the colorimetric enzymatic method using commercial kits 
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purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).  
Hepatic lipid peroxidation assay  
The MDA levels were assayed for products of lipid peroxidation by monitoring 
thiobarbituric acid reactive substance formation as described previously (Beuge & 
Aust, 1978). Lipid peroxidation was expressed in terms of MDA equivalents using an 
extinction coefficient of 1.56 × 105 M-1 cm-1 and results are expressed as nmol 
MDA/g liver.    
Hepatic biochemical assays  
Some pieces of liver were homogenized at 4°C in 10 ml of 0.1 M phosphate buffer, 
pH 7.4, containing 1% Bovine serum albumin (BSA). BSA was added to the buffer to 
protect ADH from protease attack by serving as an alternate substrate. The 
homogenate was centrifuged at 20,000 g for 20 min and the supernatant fraction was 
then centrifuged for 1 h at 100,000 g. The 100,000 g supernatant (cytosol) was used 
for ADH assays after a dialysis overnight against 0.1 M phosphate buffer, pH 7.4. All 
steps were carried out at 4°C. ADH activity was determined at room temperature at 
340 nm using an ATI Unicam UV/VIS Spectrometer (Aasmoe et al., 1998). Hepatic 
GSH content was determined as described by Ellman (1959).  
Liver sample (0.5 g) was homogenised in 10 ml ice-cold 0.01 M phosphate 0.15 
M KCl buffer at pH 7.4. The homogenate was centrifuged at 10,000 g for 15 min at 
4°C. The supernatant was used as the source of liver GST. All samples were kept on 
ice prior to use. GST activity was determined by a modification of the method use by 
Habig et al. (1974), using 1-chloro-2, 4-dinitrobenzene (CDNB) as substrate. Hepatic 
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SOD activity was assayed by its ability to inhibit the auto oxidation of hematoxylin 
into hematin following the method of Martin et al. (1987). The results were expressed 
as unit SOD/mg protein. 
Statistical analysis  
The data were analyzed using a SPSS 11.0 statistical package. The data for multiple 
comparisons were performed by one-way ANOVA followed by Dunnett t-test. A 
value of P<0.05 was considered statistically significant and all results are presented as 
the mean ± s.e.m. 
Results 
Effects of SHE on blood alcohol content in mice 
After administration of a same volume of alcohol, the concentrations of blood alcohol 
in mice were measured. As showed in Table 1, SHE significantly decreased the blood 
alcohol level at 300 and 600 mg/kg but not at the low dose, 150 mg/kg. To speak 
exactly, the elimination of alcohol in the mice treated with SHE was faster than the 
model mice.  
Effects of SHE on the levels of serum ALT, AST and hepatic TG  
Acute alcohol-induced liver injury was indicated by elevated serum ALT, AST and 
hepatic TG. The result reported in Table 2 shows the activities of serum AST, ALT 
and hepatic TG in control and experimental mice. It also indicates that ethanol 
administration significantly increased the activities of the above parameters in model 
mice after administration of alcohol 6 h later. Treatment with SHE remarkably 
reduced the elevation of serum ALT (150, 300, 600 mg/kg), AST (300, 600 mg/kg) 
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and accumulation of hepatic TG (300, 600 mg/kg) in a dose-dependent manner. 
Effects of SHE on hepatic lipid peroxidation  
As described in Table 3, the content of MDA, an ethanol metabolite, a type of 
aldehyde adduct were found remarkably increased in the model mice compared to the 
control mice. Then, the middle and high doses of SHE (300, 600 mg/kg) decreased 
the MDA level, as evidenced by closing to normal level. 
Effects of SHE on the levels of hepatic ADH, SOD, GST and GSH 
ADH is involved in the major pathway for ethanol metabolism in liver under normal 
physiological conditions. The activity of ADH increased in the model mice comparing 
to that of the normal mice. Administration of SHE (300, 600 mg/kg) significantly 
protected against alcohol-induced ADH elevation except the low dose of SHE (Table 
3).  
Table 3 also represents the levels of non-enzymatic antioxidant, GSH status in 
lives. The levels of GSH were significantly reduced in alcohol treated mice when 
compared with control rats. Administration of SHE (150, 300, 600 mg/kg) 
significantly restored the levels of non-enzymatic antioxidants in tissues.  
The activities of antioxidant enzymes namely SOD and GST in liver were given 
in Table 3. A significant decrease in the activities of enzymatic antioxidants was 
observed in alcohol treated mice when compared with control mice. Administration of 
SHE (150, 300, 600 mg/kg) along with alcohol significantly reversed these functional 
markers towards normal in a dose-dependent manner. 
Discussion 
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The results of the present study demonstrated that acute alcohol administration caused 
liver injury as evidenced by the elevation of serum ALT, AST and hepatic TG levels, 
which reflected early biochemical and pathological changes in alcoholic liver disease.  
ALT and AST are the reliable markers for liver function (Gross et al., 2009). It is 
established that AST can be found in liver, cardiac muscle, skeletal muscle, kidney, 
brain, pancreas, lungs, leukocytes and erythrocytes whereas ALT is present in liver 
(Rej et al., 1997). The increased levels of serum enzymes such as AST and ALT 
indicate the increased permeability and damage and/or necrosis of hepatocytes 
(Goldberg & Watts, 1965). In our study, we found that a large quantity of ethanol 
consumption at one time caused a significant increased in the activities of AST and 
ALT, which could lead to severe damage to tissue membrane. Pretreatment with SHE 
decreased activities of these enzymes in mice which indicated its hepatoprotective 
effect.  
Binge drinking causes fatty liver, which represents the early stage of alcoholic 
liver disease, and is usually reversible. There are multiple mechanisms underlying 
ethanol-induced development of fatty liver. Ethanol administration promotes 
fatty-acid synthesis; increases expression of some mRNAs, which promotes TG 
synthesis; and decreases expression of some mRNAs, which leads to inhibition of 
fatty acid oxidation. Additionally, results of several studies have identified 
accumulation of lipids in the liver to be the onset of ALD (Teli et al., 1995; Wanless 
& Shiota, 2004). In the present study, the hypothesis that SHE protects against early 
alcohol-induced fat accumulation was first tested in a model of acute alcohol 
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ingestion. 
Alcohol dehydrogenase (ADH) is an important enzyme that oxidizes alcohol at a 
faster rate to ease out alcohol concentration. An increase in ADH activity is followed 
by a decrease in ethanol concentration. Nevertheless we observed in this study that 
SHE decreased the activity of hepatic ADH, accompanied by the decrease of blood 
alcohol content. Actually alcohol metabolism is a complex process. Ingested ethanol 
is partly oxidized in the upper digestive tract by gastric ADH and the remaining is 
absorbed through the portal bloodstream into the liver and metabolized by hepatic 
ADH (Livy et al., 2003). The metabolism by gastric ADH means less ethanol is 
available for entry into the systemic bloodstream, resulting in lower blood ethanol 
content in the gavaged animals. Some plant extracts can facilitate ethanol metabolism 
in the gastrointestinal tract (Matsuda et al., 2002; Tinoco et al., 2009). The 
investigation of Tinoco et al (2009) indicated that the hexane extract from Laurus 
novocanariensis leaves significantly enhanced gastric ADH activity in ethanol-treated 
rats and reduced hepatic ADH activity, followed by the decrease of blood alcohol 
content, which is in accordance with our study. Another probable reason for our 
results is that SHE might have increased glycine levels, which decreased blood 
ethanol concentration by stimulating ethanol metabolism in the stomach (Iimuro et al., 
1996).  
MDA, an ethanol metabolite, was generally considered to be responsible for 
ALD. Perivenous adducts of the acetaldehyde product of ethanol metabolism and the 
MDA, product of lipid peroxidation, appear to precede necrosis and fibrosis (Niemelä 
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et al., 1995). Acute alcohol intoxication has been associated with lipid peroxidation in 
both human beings (Meagher et al., 1999) and rodents (Shaw et al., 1990; Lang et al., 
2009). SHE attenuate the toxicity of MDA on liver by depressing the hepatic MDA 
content in mice, which indicated its effect on eliminating this toxicity ethanol 
metabolite in human beings. 
The pathogenesis of alcohol-induced liver disease involves the adverse effects of 
ethanol metabolites and also oxidative tissue injury. The role of oxidative stress in the 
development of alcoholic liver disease has been suspected since the early 1960s by 
Diluzio et al. (1964) and Diluzio and Hartman (1967), who observed that alcohol 
administration promoted the oxidative breakdown of cell membranes. Our results 
confirmed the involvement of oxidative stress in acute alcohol-induced liver injury, 
and both the compromised non-enzymatic antioxidant GSH and enzymatic 
antioxidants, including SOD and GST, were restored by the treatment of SHE. 
Non-enzymatic antioxidants, such as GSH, play an excellent role in protecting 
the cell from lipid peroxidation. The depleted level of GSH in alcohol toxicity may be 
due to scavenging of toxic radicals and inhibition of the synthesis and increased rates 
of turnover (Lieber, 1997). The active constituents such as flavanols and triterpene 
glycosides were found in Hoveniae Semen Seu Fructus (Yoshikawa et al., 1995), 
which could be responsible for the reversal of antioxidant levels in tissues of alcohol 
fed mice treated with SHE. 
In addition, the toxicity profile of oral SHE was evaluated in mice in a 
single-dose acute toxicity test. Consecutive doses ranging from 1 to 22 g/kg were 
designed to assess the potential toxicity and lethal dose of oral SHE. However the 
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dose up to 22 g/kg was well tolerated, which was unassociated with any death or toxic 
side effects in 14 days’ observation.  
In summary, SHE evidently decreased the levels of serum AST, ALT and hepatic 
TG, ADH and MDA in acute hepatic injury mice induced by alcohol, reduced blood 
alcohol concentrations in acute alcoholism mice, and increased the levels of GSH, 
GST and SOD. The current data strongly indicates protective effects of SHE on the 
acute alcoholic liver injury mice, most likely through increasing the concentrations of 
antioxidants following alcohol exposure. Its function may be mediated by facilitating 
the alcohol metabolism and reducing the metabolite. However, its underlying 
mechanism of action on anti-hepatic injury induced by alcohol needs to be further 
investigated. 
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Table1. The effects of SHE on blood alcohol content in mice 
Group                        Mice              Blood alcohol content 
                                 (mg/dL) 
Alcohol                         10                394.26 ± 69.27 
SHE (150 mg/kg) + Alcohol         10                343.72 ± 61.34 
SHE (300 mg/kg) + Alcohol         10                315.83 ± 57.45* 
SHE (600 mg/kg) + Alcohol         10                283.31 ± 63.42** 
* P<0.05 ** P<0.01 compared with the Alcohol group. Data are expressed as the mean ± s.e.m.   
 
Table 2. The effects of SHE on the levels of serum ALT , AST and hepatic TG 
Goup                  Serum ALT level         Serum AST level        Hepatic TG level 
                               (U/L)                 (U/L)                (mmol/L) 
Control                     51.80 ± 3.43           147.52 ± 7.41              2.56±0.06 
Alcohol                    74.40 ± 2.87ΔΔ           302.56 ± 20.00ΔΔ                2.97 ± 0.05ΔΔ 
SHE (150 mg/kg) + Alcohol    61.80 ± 3.49*          263.88 ± 17.12              2.88±0.15 
SHE (300 mg/kg) + Alcohol    52.70 ± 4.00**        198.63 ± 19.66**            2.66±0.10*  
SHE (600 mg/kg) + Alcohol    49.20 ± 3.14**        188.74 ± 10.96**           2.54±0.05** 
ΔP<0.05, ΔΔP<0.01 compared with the control group; *P<0.05, **P<0.01 compared with the 
alcohol group. Data are expressed as the mean ± s.e.m. Ten animals were used per group. 
            
Table 3. The effects of SHE on some hepatic parameters 
Goup               Hepatic MDA level  Hepatic ADH level  Hepatic GSH level  Hepatic GST level  Hepatic SOD level 
                           (nmol/g)        (umol/min.L)       (nmol/g)         (nmol/min.mg)        (U/mg) 
Control                    35.10±1.93       272.45±12.01       6.50±012          93.84±3.38         151.80±6.6                          
Alcohol                    47.20±2.31ΔΔ    384.16±14.37ΔΔ    5.54±0.21ΔΔ      71.86±4.02ΔΔ          94.40±6.98ΔΔ 
SHE (150 mg/kg) + Alcohol     44.50±1.08           335.81±17.53          6.85±0.15**          84.67±3.46*        131.80±9.50*      
SHE (300 mg/kg) + Alcohol   36.40±1.88**     312.03±13.15**     7.90±0.18**      95.13±4.70**       142.70±10.33** 
SHE (600 mg/kg) + Alcohol   32.70±1.87**      307.31±10.36**     8.74±0.22**     123.43±7.31**       149.20±6.31** 
ΔP<0.05, ΔΔP<0.01 compared with the control group; * P<0.05, **P<0.01 compared with the 
alcohol group. Data are expressed as the mean ± s.e.m. Ten animals were used per group. 
 
 
